Infectious Diseases

The STARD-AI reporting guideline provides a standardized framework for researchers to improve the transparency and reproducibility of diagnostic accuracy studies involving artificial intelligence. Published in Nature Medicine, the initiative addresses …

Targeting GNAQ/GNA11 Mutations: Progress in Metastatic Uveal Melanoma Treatment Researchers are evaluating the antibody-drug conjugate (ADC) DYP688 as a potential treatment for patients with GNAQ/GNA11-mutant metastatic uveal melanoma or other …

Chronic sleep deprivation and the prevalence of sleep disorders have emerged as significant public health challenges, with the Centers for Disease Control and Prevention (CDC) reporting that one in three …

Advancements in Gene Therapy for Congenital Deafness: Sequential Bilateral Treatment Recent clinical progress in gene therapy for genetic hearing loss demonstrates that sequential bilateral treatment is both safe and effective, …

Human papillomavirus (HPV) has emerged as a primary driver of oropharyngeal squamous cell carcinoma (OPSCC), fundamentally shifting how clinicians approach head and neck cancer. According to the Centers for Disease …

2024 McDonald Criteria Revisions: Advances in Multiple Sclerosis Diagnosis The 2024 revisions to the McDonald criteria represent a significant evolution in the diagnosis of multiple sclerosis (MS), aiming to facilitate …

Clinical Trial NCT02658981: Investigating Relatlimab for Recurrent Glioblastoma A multicenter, phase 1 clinical trial (NCT02658981), conducted under the NCI Adult Brain Tumor Consortium (ABTC), evaluated the safety and immunological impact …

NeuroVFM: Advancing Medical Imaging Through Health System Learning Researchers at the University of Michigan have developed NeuroVFM, a generalist medical foundation model designed to interpret neuroimaging data directly from routine …

Pancreatic cancer treatment is shifting toward precision medicine as new inhibitors target the KRAS G12D mutation, a primary driver in over 90% of pancreatic ductal adenocarcinomas (PDAC). Recent clinical data …

STEM-PD Clinical Trial: First-in-Human Results for Parkinson’s Disease Cell Therapy A first-in-human clinical trial of STEM-PD—a cell therapy derived from human embryonic stem cells—has demonstrated initial safety and tolerability in …